Sun Life Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-13,893
Closed -$139K 627
2019
Q2
$139K Hold
13,893
0.04% 209
2019
Q1
$179K Buy
13,893
+75
+0.5% +$1.12K 0.04% 209
2018
Q4
$210K Buy
13,818
+70
+0.5% +$1.33K 0.04% 184
2018
Q3
$275K Buy
13,748
+86
+0.6% +$1.96K 0.05% 187
2018
Q2
$266K Buy
+13,662
New +$302K 0.04% 189

Other funds holding AMAG

Sun Life Financial's AMAG Position: Q3 2019 in Review

Sun Life Financial sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 13,893 shares — an estimated $139K sold.

Sun Life Financial first reported a position in AMAG in Q2 2018 and held it in 5 quarters. The position peaked at $275K in Q3 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Sun Life Financial reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Sun Life Financial sold 13,893 AMAG Pharmaceuticals shares in Q3 2019, an estimated $139K.
  • Sun Life Financial first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Sun Life Financial's AMAG Pharmaceuticals position peaked at $275K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Sun Life Financial's 13F filing for Q3 2019, filed 13 Nov 2019.